Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral DHEA for Sexual Function in Postmenopausal Women
NCT00289926Phase 3Completed
- Sponsor
- Monash University
- Start
- Feb 2006
- Primary completion
- Apr 2008
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in hypoactive sexual desire disorder (HSDD), sponsored by Monash University. Started Feb 2006; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT00289926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289926.